Published in TB and Outbreaks Week, May 14th, 2002
If these findings hold up in animal and human trials, the peptide, labeled MUC7 20-mer, could form the basis for promising new drugs for treating a wide range of infections, said Libuse Bobek, PhD, associate professor of oral biology in the University at Buffalo (UB) School of Dental Medicine and senior scientist on the research.
Results of the research were presented at the 2002 International Association of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week